Login / Signup

Favorable prognostic phenotype in myelodysplastic syndrome with der(1;7)(q10;p10).

Tomohiro HorioMegumi EnomotoMasaya WataraiYuuta NakanoSaki YamadaSaori MatsumuraJo KanasugiSoichi TakasugiAyano NakamuraKaori UchinoShohei MizunoSatsuki MurakamiHidesuke YamamotoIchiro HanamuraAkiyoshi Takami
Published in: EJHaem (2020)
Unbalanced translocation der(1;7)(q10;p10) is a characteristic chromosomal abnormality in myelodysplastic syndrome (MDS). The current study revealed that among 13 MDS patients with der(1;7)(q10;p10), seven cases with no apparent dysplasia also had low numbers of myeloblasts in the bone marrow and a 3-year survival rate of 86%; in contrast, the remaining six cases had a 3-year survival rate of 0% ( P =  .003). It was therefore suggested that MDS patients with der(1;7)(q10;p10) are classified into a distinct group with a favorable prognosis and another distinct group with a very poor prognosis.
Keyphrases
  • poor prognosis
  • bone marrow
  • long non coding rna
  • mesenchymal stem cells
  • magnetic resonance
  • free survival
  • gene expression
  • computed tomography
  • dna methylation
  • contrast enhanced
  • genome wide